Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia



Status:Archived
Conditions:Pneumonia
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2010
End Date:June 2012

Use our guide to learn which trials are right for you!

A Phase 2, Multi-Dose, Double-Blind, Double-Dummy, Active-Control, Randomized Study to Evaluate the Safety, Efficacy and Pharmacokinetic Profile of Two Dosing Regimens of Zabofloxacin for the Treatment of Community-Acquired Pneumonia of Moderate Severity


A double-blind, three-arm study, to evaluate the safety and efficacy of two dosing regimens
of zabofloxacin (a fluoroquinolone antibiotic) in community acquired pneumonia.


The study is a Phase 2, global, prospective, multi-dose, double-blind, double-dummy,
active-control, randomized, parallel-group, multicenter study of oral zabofloxacin HCl
(400mg) versus oral levofloxacin (500mg) in the treatment of adults with community-acquired
pneumonia of moderate severity.


We found this trial at
10
sites
Austin, Texas
?
mi
from
Austin, TX
Click here to add this to my saved trials
Birmingham, Alabama
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Celebration, Florida
?
mi
from
Celebration, FL
Click here to add this to my saved trials
Coeur D'Alene, Idaho
?
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
Detroit, Michigan
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Jeffersonville, Indiana
?
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
?
mi
from
Lima, OH
Click here to add this to my saved trials
Medford, Oregon
?
mi
from
Medford, OR
Click here to add this to my saved trials
Philadelphia, Pennsylvania
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
West Orange, New Jersey
?
mi
from
West Orange, NJ
Click here to add this to my saved trials